Elite Pharmaceuticals, Inc. (ELTP)
0.2468
0.00 (0.00%)
USD |
OTCM |
Sep 24, 16:00
Elite Pharmaceuticals Research and Development Expense (Annual) : 5.743M for March 31, 2026
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| March 31, 2026 | 5.743M |
| March 31, 2025 | 7.965M |
| March 31, 2024 | 6.883M |
| March 31, 2023 | 6.200M |
| March 31, 2022 | 4.051M |
| March 31, 2021 | 5.112M |
| March 31, 2020 | 5.532M |
| March 31, 2019 | 7.600M |
| March 31, 2018 | 9.621M |
| March 31, 2017 | 8.302M |
| March 31, 2016 | 12.43M |
| March 31, 2015 | 14.73M |
| Date | Value |
|---|---|
| March 31, 2014 | 3.959M |
| March 31, 2013 | 0.9752M |
| March 31, 2012 | 1.736M |
| March 31, 2011 | 1.385M |
| March 31, 2010 | 0.7944M |
| March 31, 2009 | 3.631M |
| March 31, 2008 | 5.796M |
| March 31, 2007 | 6.086M |
| March 31, 2006 | 4.344M |
| March 31, 2005 | 2.699M |
| March 31, 2004 | 2.075M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Nektar Therapeutics | 117.07M |
| Daré Bioscience, Inc. | 3.889M |
| Eton Pharmaceuticals, Inc. | 7.765M |
| ANI Pharmaceuticals, Inc. | 51.66M |
| Corcept Therapeutics, Inc. | 254.91M |